Accuray Incorporated's CEO to Speak at 31st Annual J.P. Morgan Healthcare Conference

SUNNYVALE, Calif., Dec. 20, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its president and chief executive officer, Joshua H. Levine , is scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco on Monday, January 7, 2013 at 9:00 a.m. PST/12:00 p.m. EST.

A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com/investors.

The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. To date, 667 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.

SOURCE Accuray Incorporated

RELATED LINKS
http://www.accuray.com